ICVTS Click here to locate an Ethicon representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Interact CardioVasc Thorac Surg 2007;6:120. doi:10.1510/icvts.2006.147546A
© 2007 European Association of Cardio-Thoracic Surgery

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Michael C. Sinclair
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sinclair, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sinclair, M. C.
Related Collections
Right arrowRelated Article

Best evidence topic - Thoracic general

ICVTS on-line discussion A

Michael C. Sinclair

Sacred Heart Hospital, 451 Chew St., Allentown, PA 18102, USA

Is talc pleurodesis safe for young patients following primary spontaneous pneumothorax?

While there is little doubt that VATs talc pleurodysis is effective in treating primary spontaneous pneumothorax [1], so are other methods (e.g. limited thoracotomy with mechanical pleural abrasion, and/or pleurectomy, and/or bullectomy.) VATs without talc or these adjuncts appears to be less reliable in preventing recurrent pneumothorax. The question asked is "safety" of the talc in this setting. Even a low incidence of adverse longterm effects of talc would be unacceptable. Talc pleurodysis for malignant effusions is a completely different issue since the patients generally have a short life expectancy. I have had one unfortunate experience in which talc pleurodysis was used for an effusion which was mistakenly thought to be malignant. The patient returned a few months later with an empyema necessitans and markedly thickened (>1 cm), fibrotic pleura. Decortication was exceedingly difficult. Did the intrapleural talc contribute to or cause the problem? I urge caution in the use of talc in young patients and suggest alternate methods of achieving pleurodysis are preferable.


    References
 Top
 References
 

  1. Hunt I, Barber B, Southon R, Treasure T. Is talc pleurodesis safe for young patients following primary spontaneous pneumothorax? Interact CardioVasc Thorac Surg doi:10.1510/icvts.2006.147546 [update!].[Abstract/Free Full Text]

Related Article

Is talc pleurodesis safe for young patients following primary spontaneous pneumothorax?
Ian Hunt, Brendan Barber, Rachel Southon, and Tom Treasure
Interactive CardioVascular and Thoracic Surgery 2007 6: 117-120. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Michael C. Sinclair
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sinclair, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sinclair, M. C.
Related Collections
Right arrowRelated Article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS